Nisoldipino [Inn-Spanish]
Brand names,
Nisoldipino [Inn-Spanish]
Analogs
Nisoldipino [Inn-Spanish]
Brand Names Mixture
Nisoldipino [Inn-Spanish]
Chemical_Formula
C20H24N2O6
Nisoldipino [Inn-Spanish]
RX_link
http://www.rxlist.com/cgi/generic/nisoldipine.htm
Nisoldipino [Inn-Spanish]
fda sheet
Nisoldipino [Inn-Spanish]
msds (material safety sheet)
Nisoldipino [Inn-Spanish]
Synthesis Reference
No information avaliable
Nisoldipino [Inn-Spanish]
Molecular Weight
388.414 g/mol
Nisoldipino [Inn-Spanish]
Melting Point
No information avaliable
Nisoldipino [Inn-Spanish]
H2O Solubility
No information avaliable
Nisoldipino [Inn-Spanish]
State
Solid
Nisoldipino [Inn-Spanish]
LogP
3.475
Nisoldipino [Inn-Spanish]
Dosage Forms
No information avaliable
Nisoldipino [Inn-Spanish]
Indication
Hypertension
Nisoldipino [Inn-Spanish]
Pharmacology
Nisoldipine, a dihydropyridine calcium-channel blocker, is used alone or with an angiotensin-converting enzyme inhibitor, to treat hypertension, chronic stable angina pectoris, and Prinzmetal's variant angina. Nisoldipine is similar to other peripheral vasodilators. Nisoldipine inhibits the influx of extra cellular calcium across the myocardial and vascular smooth muscle cell membranes possibly by deforming the channel, inhibiting ion-control gating mechanisms, and/or interfering with the release of calcium from the sarcoplasmic reticulum. The decrease in intracellular calcium inhibits the contractile processes of the myocardial smooth muscle cells, causing dilation of the coronary and systemic arteries, increased oxygen delivery to the myocardial tissue, decreased total peripheral resistance, decreased systemic blood pressure, and decreased afterload.
Nisoldipino [Inn-Spanish]
Absorption
No information avaliable
Nisoldipino [Inn-Spanish]
side effects and Toxicity
No information avaliable
Nisoldipino [Inn-Spanish]
Patient Information
Nisoldipino [Inn-Spanish]
Organisms Affected
Humans and other mammals